Obermatt

Menicon

TYO:7780 · JP3921270009
Health Care Equipment & SuppliesMedium

360

51
EV / EBIT34
Price / Owner Earnings3
Owner Earnings Yield39
Dividend Yield75
Price/Sales73
EV / Gross Profit80
Price/Book77
Return on Capital57
Cash Return on Capital42
Return on Equity56
EBIT Margin52
Gross Profitability66
Cash Conversion51
Accruals7
Owner Earnings Margin42
Sales growth27
Profit Growth15
Long-Term EPS Growth85
Reinvestment34
Price momentum91
Debt load19
Refinancing51
Debt Payback7
Liquidity72
Analyst ratings52
Opinion Changes50
Price Target Upside58
Market mood88
Value Creation13/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Menicon clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Based on 3/5 components.

Profile

CountryJapan
IndustryHealth Care Equipment & Supplies
SizeMedium
TypePublic Company
ExchangeTSE
Founded1943
Employees4
ISINJP3921270009
Last UpdateApr 2, 2026
Index & Theme
OphthalmologyManufacturingMedicalMedical Device

Description

Analysis

Middle-of-the-road

Menicon Co., Ltd. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is expensive. You pay 74.9× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone. At today's price, the market is assuming roughly 24% yearly growth; analysts expect 17%. The gap between price and consensus is worth watching: demanding expectations.

The trajectory is moderate and the balance sheet is stretched. The company scores 13/20 on our value-creation score: creating some value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
82
2023202420252026

All-time high

89

Mar 2026

All-time low

45

Jan 2025

Average rank

72

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
73
79
60
56
Price/Earnings
37
76
43
34
Price/Book
77
65
38
36
Dividend Yield
75
55
35
29
Value (overall)
74
81
38
41

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Menicon with its peers
Pegavision
TAI:6491
78
CountryTaiwan
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Nufarm
ASX:NUF
30
CountryAustralia
IndustryChemicals
SizeMedium
Full Stock Analysis →
Ansell
ASX:ANN
80
CountryAustralia
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Adeka
TYO:4401
90
CountryJapan
IndustryChemicals
SizeLarge
Full Stock Analysis →
Reynolds Consumer Products
NSQ:REYN
23
CountryNew Zealand
IndustryHousehold Products
SizeLarge
Full Stock Analysis →
J. B. Chemicals & Pharmaceuticals
NSI:JBCHEPHARM
69
CountrySingapore
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →